Back to search
SAM.govNotice d336c332f77445b58392669c75eeb2f4

6640--Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care System

Country
United States
Published
May 1, 2026
Deadline
May 7, 2026

Description

{"description":"The Minneapolis Health Care System requires Specimen Validity and Drug of Abuse Reagen Supplies with the Salient Characteristics listed below. \nThis is a sources sought looking for businesses to provide the supplies listed below for market research purposes. No awards of a contract will be made from this announcement.\nIf you are a vendor that can provide the requested information above and required supplies described below with competitive pricing, send your information (to include your organization's Unique Entity Identifier number) with a description of proof of capability to: theresa.thunder@va.gov on or before May 7th, 2026. Only emailed responses will be considered.\nAdditionally, please provide answers as appropriate to the following questions in the table below with your response to this sources sought. Failure to respond to the following questions may affect the acquisition strategy. \n1.\nIdentify your organization's socio-economic category.\n2.\nIdentify if your organization is the manufacturer of the requested supplies. If you are not the manufacturer, identify the manufacturer of the supplies that you will provide, their socio-economic category and a letter showing that your organization is an authorized distributor for the requested supplies. \n3.\nFill out the certificate under FAR Provision 52.225-2(b), identifying the item and its country of origin. ( https://www.acquisition.gov/far/part-52#FAR_52_225_2__d3401e52). If the product is a US domestic end product, write in USA for the item's country of origin.\n4.\nState whether any of the requested supplies may be ordered against a government contract awarded to your organization (e.g Federal Supply Schedule (FSS), General Services Administration (GSA), etc.).\n5.\nAddress whether your organization meets the requirements of 13 CFR 121.406 (b)(1)(i), (b)(1)(ii) and (b)(1)(iii) (https://www.ecfr.gov/current/title-13/chapter-I/part-121/subpart-A/subject-group-ECFR0fca5207262de47/section-121.406#p-121.406(b)).\n6.\nProvide estimated shipping and delivery information for the requested supplies (e.g. Expected lead time on delivery).\n \n*If applicable, VAAR 852.219-76 VA Notice of Limitations on Subcontracting Certificate of Compliance for Supplies and Products, will apply to the potential solicitation if set-aside for Veteran Owned Small-Businesses.* \n \n*If applicable, VAAR 852.212-71 Gray Market Items, will apply to the potential solicitation.*\n*If applicable, FAR 52.219-14 Limitations on Subcontracting, will apply to the potential solicitation if set-aside for Small-Businesses. *\n\n"} Solicitation Number: 36C26326Q0650 Type: Sources Sought Base Type: Sources Sought NAICS: 325413 Classification Code: 6640 Response Deadline: 2026-05-07T17:00:00-05:00 Office Address: Saint Paul, MN Place of Performance: Minneapolis, Minnesota, 55417 POC: Theresa (Tess) Thunder, theresa.thunder@va.gov, 701-239-3700

Open original notice

Get tenders like this in one daily alert

Use this notice as context when Tenqual drafts your search scope and fit criteria.

Create free alert
6640--Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care System tender | Tenqual